[
  {
    "ts": null,
    "headline": "Funds Only SWAN Retirement Portfolio: $6,000 Monthly Income",
    "summary": "Funds Only SWAN Retirement Portfolio: $6,000 Monthly Income",
    "url": "https://finnhub.io/api/news?id=340915c44dabc029c5941f4a424d90f5a0da31fe20d57bdfb8454ad30fe66cbc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739002500,
      "headline": "Funds Only SWAN Retirement Portfolio: $6,000 Monthly Income",
      "id": 132603018,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=340915c44dabc029c5941f4a424d90f5a0da31fe20d57bdfb8454ad30fe66cbc"
    }
  },
  {
    "ts": null,
    "headline": "One 'Safer' Buy In 10 February Dogs Of The Dow",
    "summary": "Verizon's dividend yield and Merckâs growth lead the Dow Dogs. Read why theyâre set for solid returns, with other top picks closely following in February 2026.",
    "url": "https://finnhub.io/api/news?id=14b4128129dde93c0054cd30e448c400a14d653d5137e8f85fb50551b472f598",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739001261,
      "headline": "One 'Safer' Buy In 10 February Dogs Of The Dow",
      "id": 132602946,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1839458057/image_1839458057.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Verizon's dividend yield and Merckâs growth lead the Dow Dogs. Read why theyâre set for solid returns, with other top picks closely following in February 2026.",
      "url": "https://finnhub.io/api/news?id=14b4128129dde93c0054cd30e448c400a14d653d5137e8f85fb50551b472f598"
    }
  },
  {
    "ts": null,
    "headline": "Terns Pharma: I Don't See The Positioning",
    "summary": "Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.",
    "url": "https://finnhub.io/api/news?id=dc255b053659bc4f6cd28a060f13a5c868e08359ca7778dd47f694cdbf82b323",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738989856,
      "headline": "Terns Pharma: I Don't See The Positioning",
      "id": 132602285,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.",
      "url": "https://finnhub.io/api/news?id=dc255b053659bc4f6cd28a060f13a5c868e08359ca7778dd47f694cdbf82b323"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of February 9",
    "summary": "Stay informed on the latest dividend activity for top companies with this weekly summary. Read more here.",
    "url": "https://finnhub.io/api/news?id=450fdd4915daefa4b2d863ad148618665374525f5d5fa3e8a28182ab7e73729d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738980015,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of February 9",
      "id": 132601739,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Stay informed on the latest dividend activity for top companies with this weekly summary. Read more here.",
      "url": "https://finnhub.io/api/news?id=450fdd4915daefa4b2d863ad148618665374525f5d5fa3e8a28182ab7e73729d"
    }
  }
]